227 related articles for article (PubMed ID: 27072699)
1. Stressing Out Hsp90 in Neurotoxic Proteinopathies.
Inda C; Bolaender A; Wang T; Gandu SR; Koren J
Curr Top Med Chem; 2016; 16(25):2829-38. PubMed ID: 27072699
[TBL] [Abstract][Full Text] [Related]
2. Hsp90 and Its Co-Chaperones in Neurodegenerative Diseases.
Bohush A; Bieganowski P; Filipek A
Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31600883
[TBL] [Abstract][Full Text] [Related]
3. Hsp90 activator Aha1 drives production of pathological tau aggregates.
Shelton LB; Baker JD; Zheng D; Sullivan LE; Solanki PK; Webster JM; Sun Z; Sabbagh JJ; Nordhues BA; Koren J; Ghosh S; Blagg BSJ; Blair LJ; Dickey CA
Proc Natl Acad Sci U S A; 2017 Sep; 114(36):9707-9712. PubMed ID: 28827321
[TBL] [Abstract][Full Text] [Related]
4. Hsp90 regulates tau pathology through co-chaperone complexes in Alzheimer's disease.
Salminen A; Ojala J; Kaarniranta K; Hiltunen M; Soininen H
Prog Neurobiol; 2011 Jan; 93(1):99-110. PubMed ID: 21056617
[TBL] [Abstract][Full Text] [Related]
5. Tau triage decisions mediated by the chaperone network.
Cook C; Petrucelli L
J Alzheimers Dis; 2013; 33 Suppl 1():S145-51. PubMed ID: 22596270
[TBL] [Abstract][Full Text] [Related]
6. Targeting Hsp90 and its co-chaperones to treat Alzheimer's disease.
Blair LJ; Sabbagh JJ; Dickey CA
Expert Opin Ther Targets; 2014 Oct; 18(10):1219-32. PubMed ID: 25069659
[TBL] [Abstract][Full Text] [Related]
7. Molecular-level interplay between intrinsically disordered clients and Hsp90.
Ramirez LM; Zweckstetter M
Curr Opin Chem Biol; 2023 Jun; 74():102304. PubMed ID: 37068388
[TBL] [Abstract][Full Text] [Related]
8. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
Waza M; Adachi H; Katsuno M; Minamiyama M; Tanaka F; Doyu M; Sobue G
J Mol Med (Berl); 2006 Aug; 84(8):635-46. PubMed ID: 16741751
[TBL] [Abstract][Full Text] [Related]
9. Translational Shift of HSP90 as a Novel Therapeutic Target from Cancer to Neurodegenerative Disorders: An Emerging Trend in the Cure of Alzheimer's and Parkinson's Diseases.
Alam Q; Alam MZ; Sait KHW; Anfinan N; Noorwali AW; Kamal MA; Khan MSA; Haque A
Curr Drug Metab; 2017; 18(9):868-876. PubMed ID: 28758577
[TBL] [Abstract][Full Text] [Related]
10. Heat shock proteins in neurodegenerative diseases: pathogenic roles and therapeutic implications.
Adachi H; Katsuno M; Waza M; Minamiyama M; Tanaka F; Sobue G
Int J Hyperthermia; 2009 Dec; 25(8):647-54. PubMed ID: 20021225
[TBL] [Abstract][Full Text] [Related]
11. Roles of heat-shock protein 90 in maintaining and facilitating the neurodegenerative phenotype in tauopathies.
Luo W; Dou F; Rodina A; Chip S; Kim J; Zhao Q; Moulick K; Aguirre J; Wu N; Greengard P; Chiosis G
Proc Natl Acad Sci U S A; 2007 May; 104(22):9511-6. PubMed ID: 17517623
[TBL] [Abstract][Full Text] [Related]
12. CHIP-ping away at tau.
Goryunov D; Liem RK
J Clin Invest; 2007 Mar; 117(3):590-2. PubMed ID: 17332887
[TBL] [Abstract][Full Text] [Related]
13. Heat Shock Protein 90 in Parkinson's Disease: Profile of a Serial Killer.
Mansour HM; Mohamed AF; Khattab MM; El-Khatib AS
Neuroscience; 2024 Jan; 537():32-46. PubMed ID: 38040085
[TBL] [Abstract][Full Text] [Related]
14. The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins.
Dickey CA; Kamal A; Lundgren K; Klosak N; Bailey RM; Dunmore J; Ash P; Shoraka S; Zlatkovic J; Eckman CB; Patterson C; Dickson DW; Nahman NS; Hutton M; Burrows F; Petrucelli L
J Clin Invest; 2007 Mar; 117(3):648-58. PubMed ID: 17304350
[TBL] [Abstract][Full Text] [Related]
15. Convergence of heat shock protein 90 with ubiquitin in filamentous alpha-synuclein inclusions of alpha-synucleinopathies.
Uryu K; Richter-Landsberg C; Welch W; Sun E; Goldbaum O; Norris EH; Pham CT; Yazawa I; Hilburger K; Micsenyi M; Giasson BI; Bonini NM; Lee VM; Trojanowski JQ
Am J Pathol; 2006 Mar; 168(3):947-61. PubMed ID: 16507910
[TBL] [Abstract][Full Text] [Related]
16. Tau Protein Squired by Molecular Chaperones During Alzheimer's Disease.
Gorantla NV; Chinnathambi S
J Mol Neurosci; 2018 Nov; 66(3):356-368. PubMed ID: 30267382
[TBL] [Abstract][Full Text] [Related]
17. The mechanism of Hsp90-induced oligomerizaton of Tau.
Weickert S; Wawrzyniuk M; John LH; Rüdiger SGD; Drescher M
Sci Adv; 2020 Mar; 6(11):eaax6999. PubMed ID: 32201713
[TBL] [Abstract][Full Text] [Related]
18. Chaperones increase association of tau protein with microtubules.
Dou F; Netzer WJ; Tanemura K; Li F; Hartl FU; Takashima A; Gouras GK; Greengard P; Xu H
Proc Natl Acad Sci U S A; 2003 Jan; 100(2):721-6. PubMed ID: 12522269
[TBL] [Abstract][Full Text] [Related]
19. Binding of Hsp90 to tau promotes a conformational change and aggregation of tau protein.
Tortosa E; Santa-Maria I; Moreno F; Lim F; Perez M; Avila J
J Alzheimers Dis; 2009; 17(2):319-25. PubMed ID: 19363271
[TBL] [Abstract][Full Text] [Related]
20. Updates on Aβ Processing by Hsp90, BRICHOS, and Newly Reported Distinctive Chaperones.
Iqbal M; Lewis SL; Padhye S; Jinwal UK
Biomolecules; 2023 Dec; 14(1):. PubMed ID: 38254616
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
